Literature DB >> 30627989

Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial.

Selwyn van Rijn1,2, Yvonne G M Roebroek1,2, Charlotte de Jonge1,2, Jan Willem M Greve3, Nicole D Bouvy4,5.   

Abstract

OBJECTIVE: To evaluate the long-term effect of the duodenal-jejunal bypass liner (DJBL) on weight loss and glycemic control.
BACKGROUND: Data on the long-term effect of DJBL treatment is still missing.
METHODS: From 2010 to 2012, 29 patients were treated with the DJBL at center A and center B, as part of a multicenter randomized controlled trial. Prior to implantation and after removal of the DJBL, all patients underwent standardized physical examination and blood sampling. Four years after removal of the DJBL, included patients underwent standardized physical examination and blood sampling as previously performed during the initial study.
RESULTS: Out of the 29 patients, 15 patients were eligible for follow-up with a median duration of 42 months. Five patients had successfully received additional bariatric surgery. Four years after explantation of the DJBL, median weight in these 15 patients was 102.0 kg (IQR 94.0-124.6), which was not statistically significantly different from the 106.1 kg at baseline (IQR 99.0-128.4). Median BMI changed from 33.1 kg/m2 (IQR 32.3-38.5) at baseline to 33.7 kg/m2 (IQR 31.2-36.9) after follow-up. Patients had a TWL of 2.2% (IQR - 1.3-5.6) compared to baseline weight. None of the parameters were significantly different after follow-up compared to baseline.
CONCLUSIONS: The effect of weight reduction of initial DJBL treatment seems to be diminished after 4 years of follow-up. However, larger prospective studies with long-term follow-up need to be conducted in the future.

Entities:  

Keywords:  Abdominal surgery; Duodenal-jejunal bypass liner; Obesity; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2019        PMID: 30627989     DOI: 10.1007/s11695-018-03659-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  21 in total

Review 1.  Mechanisms linking obesity with cardiovascular disease.

Authors:  Luc F Van Gaal; Ilse L Mertens; Christophe E De Block
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  Structural Endoscopic Techniques to Treat Obesity: A Review.

Authors:  Selwyn van Rijn; Yvonne G M Roebroek; Ad A M Masclee; Ernst L W E van Heurn; Nicole D Bouvy
Journal:  Surg Technol Int       Date:  2015-05

3.  Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.

Authors:  Paul E O'Brien; John B Dixon; Cheryl Laurie; Stewart Skinner; Joe Proietto; John McNeil; Boyd Strauss; Sharon Marks; Linda Schachter; Leon Chapman; Margaret Anderson
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

Review 4.  Mechanisms linking obesity to insulin resistance and type 2 diabetes.

Authors:  Steven E Kahn; Rebecca L Hull; Kristina M Utzschneider
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

5.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

6.  Prevalence of childhood and adult obesity in the United States, 2011-2012.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

7.  Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.

Authors:  Samuel Sultan; Manish Parikh; Heekoung Youn; Marina Kurian; George Fielding; Christine Ren
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

8.  Bariatric surgery in 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year.

Authors:  Cristóbal Maiz; Juan Alvarado; Nicolás Quezada; José Salinas; Ricardo Funke; Camilo Boza
Journal:  Surg Obes Relat Dis       Date:  2015-03-27       Impact factor: 4.734

Review 9.  Endoscopic treatment: the past, the present and the future.

Authors:  E M H Mathus-Vliegen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-11       Impact factor: 3.043

10.  Interdisciplinary European Guidelines on metabolic and bariatric surgery.

Authors:  Martin Fried; Volkan Yumuk; Jean-Michel Oppert; Nicola Scopinaro; Antonio J Torres; Rudolf Weiner; Yuri Yashkov; Gema Frühbeck
Journal:  Obes Facts       Date:  2013-10-11       Impact factor: 3.942

View more
  2 in total

1.  EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.

Authors:  Anna Obermayer; Norbert J Tripolt; Faisal Aziz; Christoph Högenauer; Felix Aberer; Florian Schreiber; Andreas Eherer; Caren Sourij; Vanessa Stadlbauer; Eva Svehlikova; Martina Brunner; Nandu Goswami; Harald Kojzar; Peter N Pferschy; Thomas R Pieber; Harald Sourij
Journal:  Biomolecules       Date:  2021-04-14

2.  First fully endoscopic metabolic procedure with NOTES gastrojejunostomy, controlled bypass length and duodenal exclusion: a 9-month porcine study.

Authors:  Jean-Michel Gonzalez; Sohaib Ouazzani; Laurent Monino; Laura Beyer-Berjot; Stephane Berdah; Nicolas Cauche; Cecilia Delattre; Joyce A Peetermans; Peter Dayton; Ornela Gjata; Darren Curran; Marc Barthet
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.